Factors affecting hematopoietic progenitor cell mobilization: an analysis of 307 patients (Q45056285)

9 December 2017

Factors affecting hematopoietic progenitor cell mobilization: an analysis of 307 patients (English)

1 reference

9 December 2017

Alfredo Mendrone

1

1 reference

9 December 2017

Cyntia Araujo Arrais

2

1 reference

9 December 2017

Rosaura Saboya

3

1 reference

9 December 2017

Dalton de Alencar Fischer Chamone

4

1 reference

9 December 2017

Frederico Luiz Dulley

5

1 reference

9 December 2017

1 December 2008

1 reference

Transfusion and Apheresis Science

9 December 2017

1 reference

9 December 2017

39

1 reference

9 December 2017

3

1 reference

9 December 2017

187-192

1 reference

Results of the EBMT activity survey 2005 on haematopoietic stem cell transplantation: focus on increasing use of unrelated donors

9 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.09.012

A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.09.012

Granulocyte-colony stimulating factor primed bone marrow and granulocyte-colony stimulating factor mobilized peripheral blood stem cells are equivalent for engraftment: which to choose?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.09.012

Economic considerations in the use of peripheral blood progenitor cells to support high-dose chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.09.012

Factors that influence collection and engraftment of autologous peripheral-blood stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.09.012

Successful mobilization of peripheral blood HPCs with G-CSF alone in patients failing to achieve sufficient numbers of CD34+ cells and/or CFU-GM with chemotherapy and G-CSF

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.09.012

Recombinant human thrombopoietin augments mobilization of peripheral blood progenitor cells for autologous transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.09.012

Successful mobilization of peripheral blood stem cells using recombinant human stem cell factor in heavily pretreated patients who have failed a previous attempt with a granulocyte colony-stimulating factor-based regimen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.09.012

The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.09.012

Matched-pair analysis of hematopoietic progenitor cell mobilization using G-CSF vs. cyclophosphamide, etoposide, and G-CSF: enhanced CD34+ cell collections are not necessarily cost-effective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.09.012

Randomized cross-over trial of progenitor-cell mobilization: high-dose cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor plus G-CSF.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.09.012

Characterization and outcome of "hard to mobilize"' lymphoma patients undergoing autologous stem cell transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.09.012

Management strategies for the hard-to-mobilize patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.09.012

Prediction of mobilisation failure in patients with non-Hodgkin's lymphoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.09.012

Collection of peripheral blood progenitor cells after the administration of cyclophosphamide, etoposide, and granulocyte-colony-stimulating factor: an analysis of 497 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.09.012

Analysis of the effect of prior therapy on progenitor cell yield: use of a chemotherapy scoring system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.09.012

Factors associated with successful mobilization of peripheral blood progenitor cells in 200 patients with lymphoid malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.09.012

Factors influencing the collection of peripheral blood stem cells in patients with acute myeloblastic leukemia and non-myeloid malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.09.012

High-dose cyclophosphamide with or without etoposide for mobilization of peripheral blood progenitor cells in patients with multiple myeloma: efficacy and toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.09.012

Effect of prior chemotherapy on hematopoietic stem cell mobilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.09.012

Good and poor mobilizing patients differ in mobilized CD34+ cell adhesion molecule profiles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.09.012

Good and poor CD34+ cells mobilization in acute leukemia: analysis of factors affecting the yield of progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.09.012

Poor mobilization is an independent prognostic factor in patients with malignant lymphomas treated by peripheral blood stem cell transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.09.012

Thalidomide in newly diagnosed multiple myeloma: influence of thalidomide treatment on peripheral blood stem cell collection yield

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.09.012

The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.09.012

Randomized trial of filgrastim versus chemotherapy and filgrastim mobilization of hematopoietic progenitor cells for rescue in autologous transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.09.012

10.1016/J.TRANSCI.2008.09.012

7 January 2021

Identifiers

DOI

1 reference

9 December 2017

1 reference